JAMES C CZIRR
CIK 1260641 · Executive Chairman · last filed 2025-11-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$39.86M
Companies
3
Total Filings
60
Lifetime Open-Market Net
-$10.57M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GALT | Director | 11,758,091 | $3.39 | $39.86M | -$7.64M | 24 | 2025-11-12 |
| GALECTIN THERAPEUTICS INC (GALTW) Delisted | Director | 6,837,524 | — | — | -$2.93M | 18 | 2017-02-01 |
| GALECTIN THERAPEUTICS INC (PRW) Delisted | 10%+ Owner | — | — | — | $0 | 1 | 2007-11-13 |
Recent Filings · Page 4 of 6
60 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-10-24 | GALECTIN THERAPEUTICS INC (GALTW) Delisted | Mixed | −63,582 | -$44.6K | EDGAR |
| 2016-04-21 | GALECTIN THERAPEUTICS INC (GALTW) Delisted | Sell (S) | −44,312 | -$74.1K | EDGAR |
| 2015-02-03 | GALECTIN THERAPEUTICS INC (GALTW) Delisted | Mixed | +73,499 | -$0 | EDGAR |
| 2015-02-02 | GALECTIN THERAPEUTICS INC (GALTW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-01-29 | GALECTIN THERAPEUTICS INC (GALTW) Delisted | Exer (M) | +500,000 | $1.50M | EDGAR |
| 2014-01-24 | GALECTIN THERAPEUTICS INC (GALTW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-01-14 | GALECTIN THERAPEUTICS INC (GALTW) Delisted | Sell (S) | −100,000 | -$1.48M | EDGAR |
| 2013-11-18 | GALECTIN THERAPEUTICS INC (GALTW) Delisted | Buy (P) | +1,000 | $6.9K | EDGAR |
| 2013-11-05 | GALECTIN THERAPEUTICS INC (GALTW) Delisted | Exer (M) | +200,000 | $600.0K | EDGAR |
| 2013-10-18 | GALECTIN THERAPEUTICS INC (GALTW) Delisted | Exer (M) | +300,000 | $900.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.